Medicare X- Overs Only
|
|
|
- Evangeline George
- 7 years ago
- Views:
Transcription
1 J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 100 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 350 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CAL 10 MG/ML VIA 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 50 MG VL 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 100 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 200 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 350 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 100 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 200 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 350 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 500 MG V 03/01/ /99/ J0640 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG LEUCOVORIN CALCIUM 500 MG V 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 250 MG VIAL 03/01/ /30/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 250 MG VIAL 03/01/ /30/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 2 GM VIAL 03/01/ /31/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG ROCEPHIN 10 GM VIAL 03/01/ /31/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM-D5W BAG 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM-D5W BAG 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM PIGGYBACK 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM PIGGYBACK 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 10 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 10 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 10 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/9999
2 J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 10 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 10 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM PIGGYBACK 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM PIGGYBACK 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 10 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/9999
3 J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 250 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 500 MG VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 1 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J0696 INJECTION,CEFTRIAXONE SODIUM,PER 250 MG CEFTRIAXONE 2 GM VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE SP 4 MG/ML VL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE SP 4 MG/ML VL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE SP 4 MG/ML VL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 10 MG/ML VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 10 MG/ML VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 4 MG/ML VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 4 MG/ML VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 4 MG/ML VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 10 MG/ML VIAL 03/01/ /99/ J1100 DEXAMETHOSONE SODIUM PHOSPHATE, 1MG DEXAMETHASONE 10 MG/ML VIAL 03/01/ /99/ J1260 INJECTION, DOLASETRON MESYLATE, 10 MG ANZEMET 20 MG/ML VIAL 03/01/ /99/ J1260 INJECTION, DOLASETRON MESYLATE, 10 MG ANZEMET 20 MG/ML VIAL 03/01/ /99/ J1260 INJECTION, DOLASETRON MESYLATE, 10 MG ANZEMET 12.5 MG CARPUJECT 03/01/ /99/ J1260 INJECTION, DOLASETRON MESYLATE, 10 MG ANZEMET 12.5 MG CARPUJECT 03/01/ /99/ J1260 INJECTION, DOLASETRON MESYLATE, 10 MG ANZEMET 20 MG/ML VIAL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALDOL DECANOATE 50 AMPUL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALDOL DECANOATE 50 AMPUL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALDOL DECANOATE 100 AMPUL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 50 MG/ML VL 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1631 HALOPERIDOL DECANOATE, PER 50 MG HALOPERIDOL DEC 100 MG/ML V 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML ISECURE 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML ISECURE 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML CARPUJEC 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML CARPUJEC 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML ISECURE 03/01/ /99/9999
4 J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML CARPUJEC 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML SYRINGE 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML SYRINGE 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC IM 30 MG/ML SYRIN 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 15 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 60 MG/2 ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 30 MG/ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 60 MG/2 ML VIAL 03/01/ /99/ J1885 KETOROLAC TROMETHAMINE, PER 15 MG KETOROLAC 60 MG/2 ML VIAL 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG AREDIA 30 MG VIAL 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG AREDIA 90 MG VIAL 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 90 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 90 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE DISOD 30 MG VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE DISOD 90 MG VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 90 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE DISOD 30 MG VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE DISOD 90 MG VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE DISOD 30 MG VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE DISOD 90 MG VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/9999
5 J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 60 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 90 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 90 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 30 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG OTN PAMIDRONATE 3 MG/ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG PAMIDRONATE 90 MG/10 ML VIA 03/01/ /99/ J2430 PAMIDRONATE DISODIUM PER 30 MG OTN PAMIDRONATE 9 MG/ML VIA 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 25 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 50 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML SYRIN 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML AMPUL 03/01/ /31/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 50 MG/ML AMPUL 03/01/ /31/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 50 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 50 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 50 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 50 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 50 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE HCL POWDER 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE HCL POWDER 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE HCL POWDER 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PROMETHAZINE HCL POWDER 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 25 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 25 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 50 MG/ML AMPUL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 50 MG/ML VIAL 03/01/ /99/ J2550 INJECTION, PROMETHAZINE HCL, UP TO 50 MG PHENERGAN 50 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL CITRATE POWDER 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML SYRINGE 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/9999
6 J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML VIAL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG SUBLIMAZE 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG SUBLIMAZE 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG SUBLIMAZE 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG SUBLIMAZE 0.05 MG/ML AMPUL 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL CITRATE POWDER 03/01/ /99/ J3010 INJECTION, FENTANYL CITRATE PER 0.1 MG FENTANYL CITRATE POWDER 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SALINE 0.9% SOLN/EXCEL CONT 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN. 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% SOLN 03/01/ /99/ J7050 INFUSION, NORMAL SALINE SOLUTION 250 CC SODIUM CHLORIDE 0.9% VIAL 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONOCLATE-P 250 UNIT KIT 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONOCLATE-P 500AHFU KIT 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONOCLATE-P 1,000 UNITS KIT 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONOCLATE-P 1,500 UNITS KIT 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONARC-M UNITS VIAL 03/01/ /99/9999
7 J7190 FACTOR VIII, HUMAN, PER IU MONARC-M UNITS VIAL 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONARC-M 801-1,700 UNITS VI 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU MONARC-M 1,701-2,000 UNITS 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU HEMOFIL M UNITS VIA 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU HEMOFIL M UNITS VIA 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU HEMOFIL M 801-1,700 UNITS V 03/01/ /99/ J7190 FACTOR VIII, HUMAN, PER IU HEMOFIL M 1,701-2,000 UNITS 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 250 UNIT VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 500 UNIT VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 1,000 UNITS VIA 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 250 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 500 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 1,000 UNITS VIA 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 2,000 UNIT VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU KOGENATE FS 2,000 UNIT VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU HELIXATE FS 250 UNIT VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU HELIXATE FS 500 UNIT VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU HELIXATE FS 1,000 UNITS VIA 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU RECOMBINATE UNIT VI 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU RECOMBINATE UNIT VI 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU RECOMBINATE 801-1,240 UNIT 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU RECOMBINATE UNIT VL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU RECOMBINATE UNIT VL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU RECOMBINATE 801-1,240 UNITS 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 250 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 500 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 1,000 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 1,500 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 1,800-2,200 UNITS VI 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 801-1,200 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 1,201-1,800 UNITS VI 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 1,801-2,400 UNITS VI 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU ADVATE 2,400-3,600 UNITS VI 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU REFACTO 1,000 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU REFACTO 500 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU REFACTO 250 UNITS VIAL 03/01/ /99/ J7192 FACTOR VIII, RECOMBINANT, PER IU REFACTO 2,000 UNITS VIAL 03/01/ /99/ J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y
8 J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLUTI 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BROMIDE POWDER 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BROMIDE POWDER 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BROMIDE POWDER 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BROMIDE POWDER 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /99/9999 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /30/2009 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /31/2009 Y J7644 IPRATROPIUM BROMIDE, PER MG IPRATROPIUM BR 0.02% SOLN 03/01/ /30/2009 Y J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 50 MG VIAL 03/01/ /30/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 10 MG VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 20 MG VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 50 MG VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG ADRIAMYCIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 10 MG VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 50 MG VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/9999
9 J9000 DOXORUBICIN HCL, 10 MG DOXORUBICIN 2 MG/ML VIAL 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLENOXANE 15 UNITS VIAL 03/01/ /31/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLENOXANE 30 UNITS VIAL 03/01/ /28/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 15 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 15 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 30 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 30 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 15 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 30 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 30 UNITS 03/01/ /99/ J9040 BLEOMYCIN SULFATE, 15 UNITS BLEOMYCIN SULFATE 15 UNITS 03/01/ /99/ J9045 CARBOPLATIN, 50 MG PARAPLATIN 50 MG VIAL 03/01/ /31/ J9045 CARBOPLATIN, 50 MG PARAPLATIN 150 MG VIAL 03/01/ /14/ J9045 CARBOPLATIN, 50 MG PARAPLATIN 450 MG VIAL 03/01/ /30/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 600 MG/60 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 600 MG/60 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG VIAL 03/01/ /31/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG VIAL 03/01/ /31/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG VIAL 03/01/ /30/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 600 MG/60 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/9999
10 J9045 CARBOPLATIN, 50 MG CARBOPLATIN 600 MG/60 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 600 MG/60 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG/5 ML VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG/15 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 50 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 150 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG VIAL 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 450 MG/45 ML VI 03/01/ /99/ J9045 CARBOPLATIN, 50 MG CARBOPLATIN 600 MG/60 ML VI 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN-AQ 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN-AQ 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9060 CISPLATIN, POWDER OR S0LUTION, PER 10 MG CISPLATIN 1 MG/ML VIAL 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG ELIGARD 22.5 MG SYRINGE 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG ELIGARD 45 MG SYRINGE 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG ELIGARD 30 MG SYRINGE 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG ELIGARD 7.5 MG SYRINGE 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT-PED 7.5 MG KIT 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT-PED MG K 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT-PED 15 MG KIT 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT 22.5 MG 3MO KI 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT 7.5 MG KIT 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT MG 3MO K 03/01/ /99/ J9217 LEUPROLIDE ACETATE, PER 7.5 MG LUPRON DEPOT-4 MONTH KIT 03/01/ /99/ J9265 PACLITAXEL 30 MG TAXOL 30 MG/5 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG TAXOL 100 MG/16.7 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG TAXOL 300 MG/50 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG ONXOL 300 MG/50 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG ONXOL 300 MG/50 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG ONXOL 30 MG/5 ML VIAL 03/01/ /99/9999
11 J9265 PACLITAXEL 30 MG ONXOL 30 MG/5 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG ONXOL 150 MG/25 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG ONXOL 150 MG/25 ML VIAL 03/01/ /11/ J9265 PACLITAXEL 30 MG PACLITAXEL 100 MG/16.7 ML V 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 300 MG/50 ML VIA 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 30 MG/5 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 100 MG/16.7 ML V 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 300 MG/50 ML VIA 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 30 MG/5 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 100 MG/16.7 ML V 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 300 MG/50 ML VIA 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 30 MG/5 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 100 MG/16.7 ML V 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 300 MG/50 ML VIA 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 30 MG/5 ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 100 MG/16.7 ML V 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 300 MG/50 ML VIA 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 6 MG/ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 6 MG/ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG PACLITAXEL 6 MG/ML VIAL 03/01/ /99/ J9265 PACLITAXEL 30 MG ABRAXANE 100 MG VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG NAVELBINE 10 MG/ML VIAL 03/01/ /31/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 50 MG/5 ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 50 MG/5 ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 10 MG/ML VIAL 03/01/ /99/ J9390 VINORELBINE TARTRATE, PER 10 MG VINORELBINE 50 MG/5 ML VIAL 03/01/ /99/ RSV IMMUNE GOBULIN, 50 MG SYNAGIS 100 MG/1 ML VIAL 03/01/ /99/ RSV IMMUNE GOBULIN, 50 MG SYNAGIS 50 MG/0.5 ML VIAL 03/01/ /99/9999
NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only
Updated 5.5.14 NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only 68152-0103-03 A9543 YTTRIUM Y-90 IBRITUMOMAB TIUXETAN ZEVALIN Y-90 VIAL 9/1/2013 12/31/2013 50419-0320-05
Drugs covered under Medicare Part B or Part D
LABEL_NAME GENERIC_NAME MESSAGE GEMZAR INJ 1 GM GEMCITABINE HCL FOR INJ 1 GM ALIMTA INJ 500MG PEMETREXED DISODIUM FOR IV SOLN 500 MG (BASE EQUIV) FUNGIZONE INJ 50MG AMPHOTERICIN B FOR INJ 50 MG KYTRIL
for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
Hydration, IV Infusions, Injections and Vaccine Charge Process
There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration
Outpatient Billing/Coding: A Focus on Missed Reimbursement & Quality of Reported Data
Outpatient Billing/Coding: A Focus on Missed Reimbursement & Quality of Reported Data 438 e wilson bridge road, suite 200 worthington, oh 43085-2382 888-779-5663 www.cleverleyassociates.com 1 All US Average
Products for the Treatment of Factor VIII Deficiency
Products for the Treatment of Factor VIII Deficiency Conference Call August 24, 2004 7pm-8pm Presenters: Marcus E. Carr, MD, PhD & Gita V. Massey, MD I. Overview of Factor VIII products currently on the
ARTICLE 4.03 AMBULANCE SERVICE* Division 1. Generally
ARTICLE 4.03 AMBULANCE SERVICE* Division 1. Generally Sec. 4.03.001 Penalty for violation Any person violating the provisions of this article shall be punished as provided in section 1.01.009. Sec. 4.03.002
RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS
RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS After the completion of this module you will be able to: Define medication reconstitution. Read a medication label. Reconstitute a medication. Calculate
J_Code To NDC Billing Cross Reference Guide
J_Code To Billing Cross Reference Guide J0129 Injection, abatacept, 10 mg GENERIC J0129 UN 250 MG 250 MG 25 ABATACEPT/MALTOSE J0150 6 MG Injection adenosine 6 MG GENERIC J0150 ML 3 MG/ML 3 MG ML 1 0.5
Acetylcysteine Inhalation Solution
Drug Shortage information Action Plan delays and another manufacturer voluntarily suspending production. Hospira has a limited supply available and other manufacturers are unable to estimate a release
Union EMS Local Formulary July 18, 2014
July 18, 2014 Forward The intent of the Union EMS Local Formulary is to provide guidance during the implementation and use of the 2012 NCCEP Protocols, Policies and Procedures to the ALS and BLS Professionals
Authorized by the U.S. District Court for the District of Massachusetts
Authorized by the U.S. District Court for the District of Massachusetts If you made a Cash Payment or Percentage Co-Payment for Certain Drugs, from January 1, 1991 to March 1, 2008, you may be able to
PREFERRED GENERIC DRUG LIST
These discount programs are NOT health insurance policies and are not intended as a substitute for insurance. The programs do not qualify as a minimum creditable coverage under Massachusetts law or where
D( desired ) Q( quantity) X ( amount ) H( have)
Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg
THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST. Date Request Received: 03 August 2015 FOI Ref: 947
FREEDOM OF INFORMATION ACT 2000 THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST Date Request Received: 03 August 2015 FOI Ref: 947 Requested Information For the Royal Cornwall Hospitals
Allergy Emergency Treatment Protocol
Allergy Emergency Treatment Protocol I. Initial evaluation of possible allergic reaction a. Cease administration of allergenic extracts b. Notify physician c. Record vital signs: blood pressure, pulse,
Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER
CHAPTER 5 Dosage Calculations L earning Objectives After completing this chapter, you should be able to: Solve one-step pharmaceutical dosage calculations. Set up a series of ratios and proportions to
Asthma, COPD and Diabetes Preferred Drug List Medications
GPI Name Dexamethasone Tab 0.5 MG Dexamethasone Tab 0.75 MG Dexamethasone Tab 1 MG Dexamethasone Tab 1.5 MG Dexamethasone Tab 2 MG Dexamethasone Tab 4 MG Dexamethasone Tab 6 MG Dexamethasone Elixir 0.5
Emergency Medications Approved for Use at VAPAHCS
Table 1: Medications (PAD GM&S) Emergency Medications Approved for Use at VAPAHCS PAD GM&S (See HCSM 11-12-35 Attachment A CPR Committee Atropine 1mg/10ml syringe X 3 Normal saline 1000ml bag X 2 Sodium
AMBULANCE BILLING FEES
AMBULANCE BILLING FEES At roughly 75% of Big Sky Fire Department responses, Emergency Medical Services and Ambulance Transports take up a large portion of the department s operating budget. While some
PHYSICIAN-ADMINISTERED MEDICATION: BILLING REQUIREMENTS
PHYSICIAN-ADMINISTERED MEDICATION: BILLING REQUIREMENTS Policy For physician-administered medication, effective April 1, 2012, Neighborhood Health Plan requires National Drug Codes (NDC) on claims in addition
A Correct. The D in the order means dextrose which provides calories.
PRACTICE PROBLEMS Practice Problem 1: The order you have is: 1000mL D5NS q 12 h The patient will receive a large or small bag of fluid? Correct answer is a. a. Large b. Small B. Incorrect. 1000mL is a
INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HIGH RISK MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
PROVIDER BULLETIN NO. 08-03
PROVIDER BULLETIN NO. 08-03 January 31, 2008 TO: Physicians, Mid-level Practitioners, and Clinics Administering Medications FROM: RE: Vivianne M. Chaumont, Director Division of Medicaid and Long-Term Care
Reconstitution of Solutions
Chapter 12 Reconstitution of Solutions Reconstitution Process of mixing and diluting solutions Some medications supplied in powder form and must be mixed with liquid before administration Parts of Solutions
Emergency Medical Items Catalogue 2002. Code Description Ind. price Ship. weight Ship. Vol.
Injectable drugs DINJACSA5V ACETYLSALICYLAT LYSINE, 0.9 g (aspirin 0.5 g), powder vial Injectable analgesic, antipyretic, anti inflammatory. Not in the WHO Essential Medicines list 2002. Action is rapid,
When calculating how much of a drug is required, working with the formula helps the accuracy of the calculation.
DRUG CALCULATIONS When calculating how much of a drug is required, working with the formula helps the accuracy of the calculation. Always remember this formula: What you want X Quantity it comes in What
Drug Dosage Practice Problems
Drug Dosage Practice Problems Topics covered: Metric Conversions ---------------------------------------------------------------- pg 2 General Conversions --------------------------------------------------------------
Cycle frequency: Every three weeks Total number of cycles: 6
Carboplatin/Paclitaxel Ovarian Cancer Adjuvant, Advanced Paclitaxel 175mg/m 2 500mls 5% dex/3hrs Day 1 Carboplatin AUC 5 500mls 5% dex/1hr Day 1 Anti-emetic group - Moderately high Paclitaxel given first
$4, 30-day $10, 90-day
$4 Prescriptions - Choose from hundreds of generic drugs and over the counter medications. Free Home Delivery Mailed right to your home Free shipping Prescription Program includes up to a 30-day supply
Appendix 4: Guidelines for Prescribing and Administering Drugs:
Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates
NOTICES DEPARTMENT OF HEALTH
NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [43 Pa.B. 3060] [Saturday, June 1, 2013] Under 28 Pa. Code 1005.11 (relating to drug use, control and security), the following drugs
Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment
A Patient s Guide Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is
Pharmacy Technician Web Based Calculations Review
Pharmacy Technician Web Based Calculations Review MODULE 3 3 2009 PRESENTED BY: Jenifer Maki, JENIFER PharmD MAKI, PHARMD BRETT SALEM, PHARMD WITH CONTRIBUTIONS DEREK LOMAS, FROM: PHARMD Brett Salem, PharmD
DRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 COVERAGE INFORMATION
ACTEMRA (toclizumab) 10/21/13 ADASUVE (loxapine aerosol powder breath activated) 01/24/14 ADDAMEL N INJ (Trace Min (CR-CU-F-FE-I-MN-MO-SE-ZN) INJ) 05/20/13 ADYNOVATE (Antihemophilic Factor Recomb Pegylated
LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio and proportion method.
LESSON ASSIGNMENT LESSON 2 Pharmacology TEXT ASSIGNMENT Paragraphs 2-1 through 2-34. LESSON OBJECTIVES After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio
IV and Drug Calculations for Busy Paramedics
IV and Drug Calculations for Busy Paramedics By Kent R. Spitler, MSEd, RN, NREMT-P EMS Educator Charlotte, North Carolina Introduction Medication calculations can cause frustration for EMS providers. Math
NO-COST PREVENTIVE CARE DRUGS
NO-COST PREVENTIVE CARE DRUGS INFORMATION FOR NON-GRANDFATHERED ASO GROUPS The Affordable Care Act (ACA) requires that certain preventive care drugs and drug categories be covered at no cost to health
Retail Prescription Program Drug List
Retail Prescription Program Drug List Price Matters New Men s Health Category Convenience Free Home Delivery Our 4 prescriptions have saved our customers over 3 billion The program is available to everyone,
Tutorial 4 SOLUTION STOICHIOMETRY. Solution stoichiometry calculations involve chemical reactions taking place in solution.
T-27 Tutorial 4 SOLUTION STOICHIOMETRY Solution stoichiometry calculations involve chemical reactions taking place in solution. Of the various methods of expressing solution concentration the most convenient
Table I: FOR CRITICAL ACCESS HOSPITAL, HOSPITAL, OFFICE-BASED SURGERY
National Patient Safety Goal- Identify and, at a minimum, annually review a list of look-alike/sound-alike drugs used in the organization, and take action to prevent errors involving the interchange of
ADENOSINE (Adenocard) Intermediate- CALL IN Paramedic. ALBUTEROL SULFATE Basic-CALL IN Intermediate-CALL IN Paramedic
ADENOSINE (Adenocard) - CALL IN ALBUTEROL SULFATE Basic-CALL IN AMIODARONE (Cordarone) - CALL IN except in cardiac arrest- call while ASPIRIN Basic ATROPINE SULFATE - CALL IN except in cardiac arrest-
Illinois Valley Community College Nursing Program Math Questions
Illinois Valley Community College Nursing Program Math Questions 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. How many mg of the antibiotic Penicillin would you prepare for a child who weighs
Human Tubal Fluid (HTF) Media & Modifi ed Human Tubal Fluid (mhtf) Medium with Gentamicin
Human Tubal Fluid (HTF) Media & Modifi ed Human Tubal Fluid (mhtf) Medium with Gentamicin HTF Media are intended for use in assisted reproductive procedures which include gamete and embryo manipulation
MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.
of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications
Cost Differences in Cancer Care Across Settings
Cost Differences in Cancer Care Across Settings August 2013 THE MORAN COMPANY 1 Cost Differences in Cancer Care Across Settings In a prior memorandum, we presented evidence documenting the growing share
Home Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
Chapter 7: Lung Cancer
Chapter 7: Lung Cancer Contents Chapter 7: Lung Cancer... 1 Small Cell... 2 Good PS + Limited stage... 2 Cisplatin/etoposide... 2 Concurrent chemotherapy + XRT... 2 Good / Intermediate PS... 2 Carboplatin
DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES
Serving the people of north east Essex DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES A Programmed Approach - It is essential you read this pack & practice the questions prior to your drug calculation
Molarity of Ions in Solution
APPENDIX A Molarity of Ions in Solution ften it is necessary to calculate not only the concentration (in molarity) of a compound in aqueous solution but also the concentration of each ion in aqueous solution.
INTRAVENOUS DRUG QUICKGUIDE
INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION
MILD TO MODERATE NOTE Medication is listed in increasing order of strength. Ascriptin (Aspirin) (P1-B1,2) - Pain reliever, anti-inflammatory
Page 1 of 6 pages Contact Surgeon before giving any medication marked with an asterisk. In an emergency or during Loss of Signal, begin appropriate treatment; then call Surgeon as soon as possible. MILD
Intravenous Push (IVP) Drug List Approved for RN Administration
Acute Care 1111Page Floor Nurses 1 of 8 Guide: Bumetanide (Bumex) - Diuretic/Acute Pulmonary Edema, CHF, and Renal disease 0.5-2 mg over 1-2 RATE 10 mg/day 0.25 mg/ml 2 mg over 2 Pain at injection Site
REFERENCE GUIDE FOR PHARMACEUTICAL CALCULATIONS
REFERENCE GUIDE FOR PHARMACEUTICAL CALCULATIONS 2014-2015 EDITION MANAN SHROFF www.pharmacyexam.com 1 This reference guide is not intended as a substitute for the advice of a physician. Students or readers
Preparation of frequently used solutions
Preparation of frequently used solutions Content 1. Diluting Concentrated Acids (Last Login: 08/08/2009) 2. Indicators (Last Login: 27/07/2009) 3. Standard Buffer Solutions (Last Login: 27/07/2009) 4.
Annex I. Article 31 of Directive 2001/83/EC. Procedure number: EMEA/H/A-31/1448
8 July 2016 EMA/472578/20166 Procedure Management and Committees Support Division List of the names, pharmaceutical s, strengths of the medicinal products, routes of, marketing authorisation s in the member
1 What Zofran Solution for Injection or Infusion is and what it is used
GlaxoSmithKline (logo) Package Leaflet: Information for the User Zofran 4 mg/2 ml (or 8mg/4 ml) Solution for Injection or Infusion ondansetron (as hydrochloride dihydrate) Read all of this leaflet carefully
Palliative Coverage Drug Benefit Supplement
Palliative Coverage Drug Benefit Supplement Effective April 1, 2015 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
HCPCS J Codes Last Updated January 2014
J s Last Updated January 2014 Term J0120 INJECTION, TETRACYCLINE, UP TO 250 MG D 19860101 19970101 J0128 INJECTION, ABARELIX, 10 MG C 20050101 20050101 J0130 INJECTION ABCIXIMAB, 10 MG D 19990101 19990101
TOTAL PARENTERAL NUTRITION SOLUTIONS
TOTAL PARENTERAL NUTRITION SOLUTIONS TOTAL PARENTERAL NUTRITION SOLUTIONS Issued 6/98 NOTE: Because of the complexity of these solutions, the customary format of the Guide cannot be used. The double entry
NOTICES. Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers
NOTICES Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers [45 Pa.B. 5451] [Saturday, August 29, 2015] Under 28 Pa. Code 1027.3(c)
DRUG DOSE CALCULATIONS
FINDING THE ORDERED DOSE The ordered dose is the most simple dosage calculation for the prehospital care provider. In this type of problem, the paramedic is given an order to administer to a patient. There
A guide for reluctant pharmacists
PHARMACY REIMBURSEMENT A guide for reluctant pharmacists Anne T. Jarrett, MS, RPh Anne T. Jarrett, MS, RPh Assistant Director of Pharmacy Wake Forest University Baptist Hospital Winston-Salem, North Carolina
List of Analytical Reagents(AR)
SAP Code 20011LL200 20011LM500 20026LM500 20042S5K25 20063S5K25 20065SR500 20070LC250 20080SG500 20080S5K50 20080SR500 20092SG100 20094SG100 20095SG500 20095S5K50 20095SR500 20118SG500 20120SG500 20120SR500
. ก ก 1. Actifed tab/syr. Triprolidine : should be stored in tight, light-resistant Pseudoepedrine : Triprolidine (p.25) Pseudoepedrine (p.
ก ก. 2553 (p.807) 3. Adrenaline inj. 1mg/ml (Epinephrine inj.) ( Druginfor. p.629) 4. Aminophylline/ Theophylline inj. (Drug infor. Ed. 11 th p.1339) 5. Amlodipine + HCTZ (Moduretic). ก ก 1. Actifed tab/syr.
Safe Medication Administration Preparation Guide C.O.R.E Essentials
Safe Medication Administration Preparation Guide C.O.R.E Essentials As a new IU Health employee, a portion of your orientation will focus on Safe Medication Administration practices. You will participate
The Impact of IV Automation on Improving Safety, Efficiency and Workflow
The Impact of IV Automation on Improving Safety, Efficiency and Workflow David Webster, RPh, MSBA University of Rochester Medical Center Department of Pharmacy Associate Director of Operations Director,
Autism Spectrum Disorder Formulation & Resource Guide
Autism Spectrum Disorder Formulation & Resource Guide Autism Spectrum Disorder Formulation & Resource Guide Knowledge Changes Everything: Quality. Innovation. Experience. Since 1974. 2015 College Pharmacy
$10.00 PRESCRIPTION PROGRAM DETAILS
$10.00 PRESCRIPTION PROGRAM DETAILS 1. The $10.00 program applies only to certain generic drugs at commonly prescribed 90 day usage dosages. (See list). 2. The Program may change without notification and
Medications most likely to be seen in primary care
Hazardous Medicines The majority of medicines are not classed as hazardous. The only medicinal products that are automatically deemed to be hazardous are cytotoxic and cytostatic medicines. There is no
ALS Ambulance. Limited (L-ALS) Laryngoscope blades (Adult) straight 1 set 1 set N/A 1 set
NAPA COUNTY EMS AGENCY Minimum Equipment Requirements ADMINISTRATIVE POLICY 4004 The following list is applicable to all EMS providers within Napa County. This list is not all inclusive and serves as a
PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
Calculations Practice Problems
Calculations Practice Problems Note: A variety of types of problems are provided for practice. Not all situations will be encountered in all states, depending on state limitations to LPN/LVN practice.
MATH FOR NURSING AND ALLIED HEALTH Math for Science webpages originally created by
1 MATH FOR NURSING AND ALLIED HEALTH Math for Science webpages originally created by Stephanie S. Baiyasi, D.V.M., Instructor, Science Division, Delta College Karen Constan, B.A., Staff Tutor, Teaching/Learning
Drug List. Medication Adult Dosing Pediatric Dosing. V-fib / pulseless V-tach 300 mg IV push Repeat dose of 150 mg IV push for recurrent episodes
Acetaminophen (Tylenol) 7-Pain Control-Adult 46-Pain Control-Pediatric 72-Fever 1000 mg po 15 mg/kg po Indicated for pain and fever control Avoid in patients with severe liver disease Adenosine (Adenocard)
DME Providers. New Requirement When Billing Drug-Related HCPCS (Including All J-Codes)
Kansas Medical Assistance Program June 2006 Vertical Perspective Provider Bulletin Number 657b DME Providers New Requirement When Billing Drug-Related HCPCS (Including All J-Codes) To comply with Centers
BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013
BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013 Validity of this document: December 2013 API Name Business Unit Page API Name Business Unit Page Acebutolol hydrochloride
March 2011 Newsletter n 12
Welcome to the STABILIS users for this twelth Newsletter! SUMMARY March 2011 Newsletter n 12 News from the ESCP-ESCP meeting in Lyon France October 2010 News from the APFH Congress Congress, Estoril, Portugal
Chapter 15. Reconstitution and Dosages Measured in Units. Copyright 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.
Chapter 15 Reconstitution and Dosages Measured in Units 1 Objectives Calculating drug dosage problems that first require reconstitution of a powdered drug into a liquid form Using a proportion to solve
2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies
2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies Legislative Authority: Health Insurance Act (Standard Hospital Benefit) Regulations 1971- Section 3(xv) This schedule lists the
Medication Safety Overview
Medication Safety Overview Focus on Look-alike Sound-alike Medications Rita Montone, RPh, MBA Operations Manager Department of Pharmacy Bayhealth Medical Center Medication names and packaging There are
Community Pharmacists in NHS Rotherham
SERVICE LEVEL AGREEMENT TO ENABLE COMMUNITY PHARMACISTS IN NHS ROTHERHAM TO PROVIDE PALLIATIVE CARE DRUGS AS LOCAL ENHANCED SERVICE PREPARED BY: NHS Rotherham CCG Medicines Management Team on behalf of
Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013
Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013 Access to palliative care drugs out of hours Agreement set up with local community pharmacy s to hold stock of commonly prescribed
How To Get A Generic Drug From A Pharmacy Benefit Manager
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014 ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ HAZARD? HAZARD ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ ENCLOSURE Substitution ส งค กคามซ งอาจเป นอ นตรายต
Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid www.mass.gov/masshealth
Executive Office of Health and Human Services Office of Medicaid www.mass.gov/masshealth February 2012 TO: FROM: RE: Physicians Participating in Julian J. Harris, M.D., Medicaid Director (2012 HCPCS) This
For Educational Use Only - Not for Detailing or Distribution
This document is intended for healthcare professionals practicing in the United States and may contain information that has not been approved by the FDA. It is supplied to you as a professional courtesy
Cycle frequency: Every three weeks Total number of cycles: 3 or 4
BEP 3-day (Bleomycin/Etoposide/Cisplatin) Germ cell tumours Bleomycin 30,000iu 200mls N. Saline/30mins Days 2, 8 & 15 Etoposide 165mg/m 2 1L N. Saline/1hr Days 1, 2 & 3 Cisplatin 50mg/m 2 1L N. Saline/4hrs
YAKUGAKU ZASSHI 126(4) 289 295 (2006) 2006 The Pharmaceutical Society of Japan
YAKUGAKU ZASSHI 126(4) 289 295 (2006) 2006 The Pharmaceutical Society of Japan 289 Notes Usefulness of the Final Filter of the IV Infusion Set in Intravenous Administration of Drugs Contamination of Injection
CHEMICAL FORMULAS AND FORMULA WEIGHT CALCULATIONS
CHEMICAL FORMULAS AND FORMULA WEIGHT CALCULATIONS 1. THE MEANING OF A CHEMICAL FORMULA A chemical formula is a shorthand method of representing the elements in a compound. The formula shows the formulas
Synagis (Palivizumab)
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
Generic Pharmacy Discount
Generic Pharmacy Discount 83 Park Place Blvd Suite 101 Clearwater, FL 33759 Fourth Quarter 2014 727.461.6044 800.314.0088 Pharmacies Generic Discount Program Information Enclosed information provided
January 31, 2002 (775) 687-4704 COMPANY AND PRESIDENT PLEAD GUILTY TO MEDICAID FRAUD
FRANKIE SUE DEL PAPA Attorney General STATE OF NEVADA OFFICE OF THE ATTORNEY GENERAL 100 N. Carson Street Carson City, Nevada 89701-4717 Telephone (775) 684-1100 Fax (775) 684-1108 WEBSITE: http://ag.state.nv.us
COUNTY OF SAN DIEGO EMERGENCY MEDICAL SERVICES No. P-117a POLICY/PROCEDURE/PROTOCOL Page 1 of 6
POLICY/PROCEDURE/PROTOCOL Page 1 of 6 GREY/PINK Kg range: < 8 kg Approx Kg: 5 kg 1 st 2 nd 3 rd Approximate LBS: 10 lbs Defib: 10 J 20 J 20 J ET uncuffed tube size: 3.5 Cardiovert: 5 J 10 J 10 J ET cuffed
About chemotherapy for lung cancer
About chemotherapy for lung cancer This information is about chemotherapy for lung cancer. There are sections on What is chemotherapy? Chemotherapy for small cell lung cancer Chemotherapy for non-small
On Demand Availability of Palliative Care Drugs Service
On Demand Availability of Palliative Care Drugs Service Locally Enhanced Service Author: Peer Review: Produced For review April 2013 Ruth Buchan, Senior Pharmacist Julie Landale, HoMM NHS Calderdale 4th
Crash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University
Crash Cart Drugs Drugs used in CPR Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University Introduction A list of the drugs kept in the crash carts. This list has been approved by the